S*Bio Alternatives & Competitors

12 companies similar to S*Bio — Pioneering the future of cancer treatment through innovative small molecule drug...

858 Therapeutics

Discovering innovative small molecule therapeutics for the treatment of cancer

30 Venture round $105.23M

San Diego, United States

Biotechnology Health Care +1

Advenchen Laboratories, LLC

Pioneering novel therapies with promising small molecule kinase inhibitors for a brighter...

6 Venture round $4.48M

Biotechnology Health Care +1

Synta Pharmaceuticals

Innovating patient care with advanced small molecule therapies for severe medical conditio...

Post-IPO Equity $217.35M

Biotechnology Health Care +1

ABM Therapeutics

An innovative drug discovery company focusing on targeted therapy for brain cancers as wel...

5 Series B $50.00M

San Diego, United States

Biopharma Biotechnology +2

Track all S*Bio competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

Inthera Bioscience

Advancing the future of cancer treatment with innovative small molecule therapies using pr...

2-10 Series A $18.60M

Biotechnology Health Care +1

Cybrexa Therapeutics

Changing the paradigm for cancer treatment through the development of antigen-independent...

11 Series B $44.40M

New Haven, United States

Biotechnology Health and Wellness +1

AlloMek Therapeutics LLC

Dedicated to advancing cancer treatment through innovative MEK kinase inhibitors.

1 Pre-Seed $150.00K

Biotechnology Health and Wellness +1

Redx Pharma

Biotech company focusing on the discovery and development of novel targeted medicines to t...

39 Post-IPO Equity $78.90M

United Kingdom

Biotechnology Health Care +1

TOLREMO therapeutics

Stopping non-genetic cancer drug resistance as it emerges

14 Series A $48.90M

Basel, Switzerland

Biotechnology Pharmaceutical

Polymed Biopharmaceuticals

Polymed creates novel PROTAC therapies for cancers and immunology HPB-143 (IRAK4) & HPB-...

2 Series A

Hangzhou, China

Biotechnology Pharmaceutical

Tetralogic Pharmaceuticals

10 Convertible Note $164.00M

Biotechnology Health Care +1

Inspirna, Inc.

Converting cancer to a manageable, chronic condition

12 Series D $144.60M

New York, United States

Biotechnology Health Care +1

About S*Bio

S*Bio is a Singapore-based biotech company founded in 2000 and operating as a subsidiary of Chiron Corporation Limited. Specializing in Biotechnology and Pharmaceutical industries, the company is focused on pioneering the future of cancer treatment through innovative small molecule drugs. The latest investment of $5.00...

Business keywords

Biotech Industry, Cancer Treatment, Drug Discovery, Small Molecule Drugs, Singapore-based, Clinical Development, Targeted Therapies, Oncology, Chiron Corporation Limited, Innovation

Frequently Asked Questions

Companies similar to S*Bio include 858 Therapeutics, Advenchen Laboratories, LLC, Synta Pharmaceuticals, ABM Therapeutics, Inthera Bioscience. They work in Biotechnology and Pharmaceutical and share S*Bio's focus on drug discovery, cancer treatment and oncology.

Bounce Watch lists 12 companies that share S*Bio's industries and are closest to it in business tags, services, target customers, business model and size.

Don't just read about them. Follow them.

BounceWatch watches S*Bio and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

S*Bio Profile 858 Therapeutics Alternatives Advenchen Laboratories, LLC Alternatives Synta Pharmaceuticals Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at S*Bio on 11 Sep 2024. The 12 companies listed here were last checked between 26 Jul 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.